Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 1Astrocytoma 1

Interventions

Temozolomide 6Magnetic Resonance Spectroscopy 5Specimen Handling 4Radiotherapy 4Radiation 3trametinib 2dabrafenib 2Radiotherapy, Intensity-Modulated 2Bevacizumab 2vorasidenib 1veliparib 1trastuzumab deruxtecan 1ribociclib 1Spinal Puncture 1Protons 1Proton Therapy 1Pluvicto 1Nivolumab 1Magnetic Resonance Imaging 1Ipilimumab 1Flucytosine 1Everolimus 1Carboplatin 1CTLA-4 Antigen 1AZD1390 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × Flucytosine × 30 days × Clear all
NCT06264388 2026-05-28

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

University of Miami

Phase 2 Recruiting
33 enrolled
CNS

Astrocytoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡